Atlas Trials

Metformin Hydrochloride in Combination With Standard of Care Systemic Therapy in Previously Untreated Advanced Unresectable or Metastatic Soft Tissue Sarcoma

Clinical trial NCT07291297 · RECRUITING

Trial details

NCT number
NCT07291297
Sponsor
Wake Forest University Health Sciences
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Sarcoma MetastaticSarcoma, Soft Tissue
Start date
2026-03-04
Primary completion
2028-10-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.